Wolters Kluwer N.V. (WKL.AS)
| Previous close | 147.50 |
| Open | 147.10 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 147.05 - 148.45 |
| 52-week range | 105.15 - 149.15 |
| Volume | |
| Avg. volume | 469,144 |
| Market cap | 35.292B |
| Beta (5Y monthly) | 0.26 |
| PE ratio (TTM) | 36.26 |
| EPS (TTM) | 4.09 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 2.08 (1.41%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | 149.50 |
Business WireGlobal Pharmaceutical Companies Turn to Wolters Kluwer to Boost Research Automation & Efficiency
WALTHAM, Mass., May 09, 2024--In the highly regulated pharmaceutical industry, implementing the latest technologies to help bring medical breakthroughs to market is of critical importance. That is why Wolters Kluwer Health has collaborated with some of the leading pharmaceutical companies to bring intuitive and easy-to-use workflows to the Ovid® research platform.
- Business Wire
Wolters Kluwer wins Best ESG Risk Management Solution at ESG Insight Awards
NEW YORK, May 09, 2024--Wolters Kluwer, a global leader in information, software, and services for professionals, announces that its OneSumX for ESG and Climate Risk Management solution has been recognized as Best ESG Risk Management Solution at the 2024 ESG Insight Awards.
- Globe Newswire
Share Buyback Transaction Details May 2 – May 8, 2024
PRESS RELEASE Share Buyback Transaction Details May 2 – May 8, 2024 Alphen aan den Rijn - May 9, 2024 - Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 131,949 of its own ordinary shares in the period from May 2, 2024, up to and including May 8, 2024, for €19.0 million and at an average share price of €144.20. These repurchases are part of the share buyback program announced on February 21, 2024,
